Blocking α1 Adrenergic Receptor as a Novel Target for Treating Alzheimer's Disease
{{output}}
While amyloidopathy and tauopathy have been recognized as hallmarks in Alzheimer's disease (AD) brain, recently, increasing lines of evidence have supported the pathological roles of cerebrovascular changes in the pathogenesis and progression of AD. Restoring ... ...